Controversies in the diagnosis and management of laryngopharyngeal reflux disease

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 14, Issue 3, 2006, Pages 113-115

  Kendall, Katherine A ^a  

^a PARK NICOLLET CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; EPIDERMAL GROWTH FACTOR; IRRITANT AGENT; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EDITORIAL; EXPOSURE; GASTROINTESTINAL TRACT; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNX DISORDER; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL SPECIALIST; META ANALYSIS; NASOPHARYNX; PATIENT COMPLIANCE; PH MEASUREMENT; PHARYNX DISEASE; PRIORITY JOURNAL; REFLUX SYMPTOM INDEX; RELIABILITY; SALIVA LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STOMACH ACID; STOMACH PH; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT INDICATION; VALIDATION STUDY;

GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; PHARYNGEAL DISEASES;

EID: 33744951059     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000193195.47720.c3     Document Type: Editorial

References (21)

1. Vincent DA, Garrett JD, Radionoff SL, et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000; 14:247-254.
2. Merati AL, Lim HJ, Ulualp SO, Toohill RJ. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005; 114:177-182.
3. Wo JM, Hunter JG, Waring JP. Dual-channel ambulatory esophageal pH monitoring: a useful diagnostic tool? Dig Dis Sci 1997; 42:2222-2226.
4. Bilgen C, Ogut F, Kesimli-Dinc H, Kirazli T, Bor S. The comparison of an empiric pump inhibitor trial vs 24 hr double-probe pH monitoring in laryngopharyngeal reflux. J Laryngol Otol 2003; 117:386-390.
5. Fraser AG, Morton RP, Gillibrand J. Resumed laryngo-pharyngeal reflux: investigate or treat? J Laryngol Otol 2000; 114:441-447.
6. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111:2147-2151.
7. Steward DL, Wilson KM, Kelly DM, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-controlled trial. Otolaryngol Head Neck Surg 2004; 131:342-350.
8. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005; 115:1230-1238.
9. Renato JG, Sullivan D, Rothstein SG. Compliance with antireflux therapy in patients with otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 2000; 110:19-22.
10. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). Journal of Voice 2002; 16:274-277.
11. Park KH, Choi SM, Kwon SUK, et al. Diagnosis of laryngopharyngeal reflux disease among globus patients. Otolaryngol Head Neck Surg 2006; 134:81-85.
12. Noordzij PJ, Khidr A, Desper E, et al. Correlation of pH probe-measured-laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002; 112:2192-2195.
13. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002; 16:564-579.
14. Belafsky PD, Postma GN, Koufman JA. The vailidy and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111:1313-1317.
15. Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique. Laryngoscope 2005; 115:2256-2261.
16. Branski RC, Bhattacharya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002; 112:1019-1024.
17. Beaver MES, Stasney CR, Weitzel E, et al. Diagnosis of laryngopharyngeal reflux disease with digital imaging. Otolaryngol Head Neck Surg 2003; 128:103-108.
18. +-ATPase) expression in human laryngeal sermucinous glands. Otolaryngol Head Neck Surg 2005; 133:718-724.
19. Eckley CA, Michelsohn N, Rizzo LV, et al. Salivary epidermal growth factor concentration in adults with reflux laryngitis. Otolaryngol Head Neck Surg 2004; 131:401-406.
20. Johnson N, Knight J, Dettmar PW, et al. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004; 114:2129-2133.
21. Costa HO, Neto OM, Eckley CA. Is there a relationship between the pH and volume of saliva and esophageal pH-metry results? Dysphagia 2005; 20:175-181.